Free Trial

More results...

Filter by Content types
Regulatory databases
Regulatory reports
Market reports
News analysis
Filter by Geography
Africa
Asia
Australasia
Europe
United Kingdom
North America
United States
South America

Alerts LATEST ALERTS

  • Arizona - United States ADA announces new cannabis delivery rules ...
  • United Kingdom ACMD supports proposal to raise maximum THC content in hemp ...
  • Ireland Parliamentary report recommends legalisation of cannabis clubs ...
  • Pakistan SIFC to meet to discuss establishing cannabis regulatory authority ...
  • Europe Initiatives to abolish hemp notification open for comment ...
  • United States Harris includes legalising recreational cannabis on priorities list ...
  • Belgium Positive list of notified herbal products is updated ...
  • Costa Rica Regulations for cannabis law published in Official Gazette ...
  • Australia Medical cannabis prescriptions reach an all-time high ...
  • Czech Republic President signs proposal to regulate hemp extracts with HHC and THC ...
  • Europe EUDA study shows concern over semi-synthetic cannabinoids ...
  • Costa Rica Pharmacies to start medical cannabis sales in January 2025 ...
View all
News analysis

UK NHS study first to test CBD and THC drugs together in treatment of epilepsy

Written by || 30th October 2024 || News analysis | Cannabis – medical | CBD | GeographiesAsia Europe Japan North America United Kingdom United States

Two CBD- and THC-based drugs to treat child epilepsy will be tested in the UK next year in a trial recruiting 500 patients across the country.

The research, to be conducted by investigators at University College London (UCL) and the Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), will be co-funded by the National Health Service (NHS) and the National Institute for Health and Care Research (NIHR).

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber

Login

Tiziana Cauli

Senior reporter/health & science editor
Tiziana is an Italian journalist from Sardinia. She has worked for both international and local media in Italy, South Africa, France, Spain, the UK, Lebanon and Belgium. She also worked as a communications manager for several international NGOs in the humanitarian sector.

Our Key Benefits

The global cannabis market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

CannIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.